Dr. Hans-Jürgen Thorns Biologie-Bedarfs-Handel

OncoMethylome shareholders pass all resolutions at AGM and appoint three new independent directors

Go to page

Medicago succesfully expresses VLP antigen for A H1N1 strain

Go to page

ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

Go to page

Merck Boosts Commercial Capacity in France - Merck has opened a commercial facility for its new Millipore® CTDMO Services offering at the company’s site in Martillac, France

Go to page

"Make two out of one" - Division of Artificial Cells - Scientists uncover a novel and generic mechanism for the division of artificial cells into two daughter cells

Go to page

Avilex Pharma receives Wellcome Trust Translation Award

Go to page

NetScientific appoints Dr François R. Martelet as Chief Executive Officer

Go to page

Dendreon Announces Strategic Realignment to Focus on PROVENGE BLA and Commercialization

Go to page

Institut für Gewässerschutz MESOCOSM GmbH - Homberg / Ohm, Germany

Go to page

Thomas Meier to become new COO of Bachem Group

Go to page

Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics - Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing

Go to page

Celera Diagnostics Identifies Novel Genetic Markers Linked to Increased Risk of Heart Attack - Discoveries Presented at the International Vascular Biology Meeting; Expanded Understanding of Disease Biology Creates Diagnostic and Therapeutic Opportunities

Go to page